Academic literature on the topic 'Aristolochia acids'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Aristolochia acids.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Aristolochia acids"
Da Silva, Antonio Jorge Ribeiro, Maria Auxiliadora Coelho Kaplan, Celuta Sales Alviano, Daniela Sales Alviano Moreno, Davi Oliveira e. Silva, and Péricles Barreto Alves. "Determination of Aristolochic Acids I and II in Brazilian Sugar Cane Spirit Infusions “milhomem” Commonly used in Northeast Brazil as Popular Drinks." Revista Fitos 14, no. 01 (March 31, 2020): 38–44. http://dx.doi.org/10.32712/2446-4775.2020.808.
Full textHoughton, Peter J., and Muzaffer Ogutveren. "Aristolochic acids and aristolactams from Aristolochia auricularia." Phytochemistry 30, no. 1 (January 1991): 253–54. http://dx.doi.org/10.1016/0031-9422(91)84131-b.
Full textZhang, Hong-Chi, Rui Liu, Zhi-peng An, Hui Li, Rui Zhang, and Feng Zhou. "Aristolactam-type alkaloids and aristolochic acids from Aristolochia moupinensis and Aristolochia cathcartii." Biochemical Systematics and Ecology 65 (April 2016): 198–201. http://dx.doi.org/10.1016/j.bse.2016.02.028.
Full textYun, Byeong Hwa, Viktoriya S. Sidorenko, Thomas A. Rosenquist, Kathleen G. Dickman, Arthur P. Grollman, and Robert J. Turesky. "New approaches for biomonitoring exposure to the human carcinogen aristolochic acid." Toxicology Research 4, no. 4 (2015): 763–76. http://dx.doi.org/10.1039/c5tx00052a.
Full textAl-Busafi, Saleh, Munir Al-Harthi, and Bushra Al-Sabahi. "Isolation of Aristolochic Acids from Aristolochia Bracteolata and Studies of their Antioxidant Activities." Sultan Qaboos University Journal for Science [SQUJS] 9 (June 1, 2004): 19. http://dx.doi.org/10.24200/squjs.vol9iss0pp19-23.
Full textNascimento, Isabele R., and Lucia M. X. Lopes. "Diterpene esters of aristolochic acids from Aristolochia pubescens." Phytochemistry 63, no. 8 (August 2003): 953–57. http://dx.doi.org/10.1016/s0031-9422(03)00335-2.
Full textPriestap, Horacio A. "Minor aristolochic acids from Aristolochia argentina and mass spectral analysis of aristolochic acids." Phytochemistry 26, no. 2 (January 28, 1987): 518–29. http://dx.doi.org/10.1016/s0031-9422(00)81447-8.
Full textChan, Chi-Kong, Yushuo Liu, Nikola Pavlović, and Wan Chan. "Aristolochic Acids: Newly Identified Exposure Pathways of this Class of Environmental and Food-Borne Contaminants and its Potential Link to Chronic Kidney Diseases." Toxics 7, no. 1 (March 19, 2019): 14. http://dx.doi.org/10.3390/toxics7010014.
Full textSantander, Rocío, Alejandro Urzúa, Ángel Olguín, and María Sánchez. "Temporal Variation of Aristolochia chilensis Aristolochic Acids during Spring." Molecules 20, no. 11 (November 13, 2015): 20391–96. http://dx.doi.org/10.3390/molecules201119704.
Full textTian-Shung, Wu, Ou Li-Fei, and Teng Che-Ming. "Aristolochic acids, aristolactam alkaloids and amides from Aristolochia kankauensis." Phytochemistry 36, no. 4 (July 1994): 1063–68. http://dx.doi.org/10.1016/s0031-9422(00)90492-8.
Full textDissertations / Theses on the topic "Aristolochia acids"
Liang, Qing You. "Study on supercritical fluid extraction of aristolochic acids in Aristolochia plants." Thesis, University of Macau, 2007. http://umaclib3.umac.mo/record=b1676801.
Full textCheung, Thomas Pak Fai, and tom cheung@rmit edu au. "Risk assessment and determination of aristolochic acids and heavy metals in Chinese herbal medicines." RMIT University. Health Sciences, 2007. http://adt.lib.rmit.edu.au/adt/public/adt-VIT20080414.145522.
Full textAlamin, Abdelgadir. "Apport de la chromatographie de partage centrifuge à l'étude phytochimique de 3 plantes utilisées en médecine traditionnelle soudanaise." Thesis, Tours, 2016. http://www.theses.fr/2016TOUR3812/document.
Full textThis work was a contribution to the phytochemical study of three Sudanese medicinal plants: Aristolochia bracteolata (Whole plant), Ziziphus spina-christi (Leaves) and Hydnora abyssinica (Rhizomes). The specificity of this research program was to emphasize the application of Centrifugal Partition Chromatography (CPC) for the fractionation of these plants. Three specific CPC methodologies were developed for the purification of either aristolochic acids, flavonoids or proanthocyanidins (PACs). In this context, the first part of this manuscript was devoted to the presentation of the CPC methodology. The second part focused on the fractionation of crude extract of Aristolochia bracteolata. This plant is used in traditional medicine, in spite of the presence of aristolochic acids that confer a high nephrotoxicity. In this work was developed an innovating procedure for the isolation and purification in high purity of aristolochic acids I, II and IIIa, in one step from crude extract, using Strong Ions eXchange CPC (SIX-CPC). These results were published in 2015 in Separation and Purification Technology. In the third part, the flavonosides present in Z. spina-christi were isolated using CPC, either in normal or reverse elution mode, using two phases solvent systems EtOAc/n-BuOH/MeOH/H2O or EtOAc/n-BuOH/H2O with different ratios. In the last part, the phytochemical study of Hydnora abyssinica led to the fractionation of PACs, polymers of high molecular weight of flavanols. The CPC fractionation methodology, preceded by LH-20 resin pre-fractionation, allowed the isolation of katsumadine and rhodioloside
Zhou, Li, and 周莉. "The molecular mechanisms of aristolochic acid nephropathy." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2009. http://hub.hku.hk/bib/B43224349.
Full textZhou, Li. "The molecular mechanisms of aristolochic acid nephropathy." Click to view the E-thesis via HKUTO, 2009. http://sunzi.lib.hku.hk/hkuto/record/B43224349.
Full textRodriguez, Isela Iveth Gonzales. "Avaliação da atividade antiofídica de \"Aristolochia sprucei\": Isolamento e caracterização estrutural de composto bioativo." Universidade de São Paulo, 2010. http://www.teses.usp.br/teses/disponiveis/60/60134/tde-01092010-005832/.
Full textA lot of species of genus Aristolochia (Familia Aristolochiacheae) have been used in traditional medicine and folk, such as medicaments and tonics, which show pharmacological activities of clinic and medical interest, like antihemorragic, antiparasitic, antibacterial, antifungic, analgesic, antitumoral between others. Expecting to get more information about these plants and in the search by substances with antiophidic effects, in this work was evaluated the action of aqueous, metanolic and ethyl acetate extracts from leaves and stems of Aristolochia sprucei against the toxic action of Bothrops asper venom, both native from Panamá and against the myotoxic effect of Bothrops jararacussu venom and BthTX1 (isolated from B. jararacussu) and Mtx-II (isolated from Bothorps asper). The leaves extracts in ethyl acetate showed the best inhibition registered of PLA2 activity of venom de B. asper showing inhibition of 45 %, 35 % and 33 %, in proportion (m/m) of 1:5, 1:10 and 1:30 respectively. As regards to stem extract in ethyl acetate, it showed high efficacy in neutralization of coagulant activity, besides It inhibited 96 %, 92 % and 87 % of edema, myotoxicity and hemorrhage induced by B. asper venom, respectively. One of bioactives components was isolated from stem extract of this plant by CLAE and the chemical characterization by nuclear magnetic resonance, this showed that the compound is the aristolochic acid. This compound inhibited the myotoxic activity of B. jararacussu and B. asper venom in 80 % and 85 %, so like myotoxic activity of BthTx-I and MTx-II in 64 % and 60 % respectively. The indirect hemolytic activity of B. asper venom was inhibited in 43 % by the aristolochic acid. The analyze of spectrum of circular dichroism and the studies of interaction by molecular modelagem suggest that the aristolochic acid forms a complex 1:1 with the miotoxin inhibiting their activity. The joint of aristolochic acid with the miotoxins (MjTX-1, BthTx-II) changes the way and the intensity of spectra from dichroism circular of miotoxin and It induced alteration in percentage of several domains that constitute a secondary structure from this toxin. The results obtained confirm that the extracts of A. sprucei have antiophidic properties and it suggest the necessity of deepen studies that allow to use with safety the extracts and the isolated active principle, like antiserum supplements to increase the efficacy in the neutralization of local toxics effects of snakes venoms.
Duquesne, Marilyn. "A translational study of the nephrotoxicity of aristolochic acids by a metabonomic approach in NMR spectroscopy validated by conventional biomarkers." Doctoral thesis, Universite Libre de Bruxelles, 2018. http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/268946.
Full textDoctorat en Sciences biomédicales et pharmaceutiques (Médecine)
info:eu-repo/semantics/nonPublished
Srđan, Živojinov. "Razvoj animalnog modela nefrotoksične tubulointersticijalne lezije." Phd thesis, Univerzitet u Novom Sadu, Medicinski fakultet u Novom Sadu, 2016. http://www.cris.uns.ac.rs/record.jsf?recordId=99867&source=NDLTD&language=en.
Full textIn the experimental procedure of dissertation, NMRI strain mice were treated with infusion of plants Aristolochia clematitis. Dried leaves, branches and fruit plants are submerged in boiling water and left to stand for 3-5 hours, and then filtered through filter paper. It was made a solution of the plant / water of 10g / 1000ml (1%), 20g / 1000ml (2%) and 40g / 1000ml (4%). Different concentrations of infusions were given to mice to drink an unlimited amount for a period of 7 weeks. So we formed the three test groups, the first who received 1% infusion, the second received 2% infusion and third received 4% infusion and a control group that received only water to drink. In each group there were 20 animals. Thus, developed an animal model of chronic toxicity. At the end of the experiment was performed histopathological analysis of kidneys, macroscopic examination of organs and measuring urine output during the experiment. We performed a complete analysis of urine, which is the determination of: color, appearance, pH, specific gravity, protein and urine sediment. Urinalysis were repeated every 7 days during the 7 weeks of the study. At the end of the experiment were analyzed for biochemical parameters (glucose, urea, creatinine, uric acid, total bilirubin, direct bilirubin, total proteins, sodium and potassium) and analysis of the complete blood count. It has been found that Aristolochia clematitis is extremely nephrotoxic plant. Identified histopathological changes of tubules and interstitium of NMRI mouse, which were the biggest in the test group receiving biggest dose. Established histopathological changes are similar to those described by pathological changes of tubulointerstitial injury of patients with Balkan endemic nephropathy. Not established the existence of cancer of the upper urinary tract. Macroscopic examination at autopsy of experimental animals, did not determine significant changes in the kidneys. There is first an enormous increase in diuresis in the first and second week of follow-up, in the second and third experimental groups retrospectively, that after 7 weeks of research, diuresis in all test groups was lower than the control group. There is an increase of urea at the end of the research, which is twice higher in the third experimental group compared to the control. There is a marked decrease in uric acid at the end of the research in the experimental group 3. There is a marked decrease in granulocytes in the leukocyte formula in all test groups, and the highest in the third test group. As the decline in the relative values of granulocytes, so there has been a rise in the relative values of lymphocite in the first and second test group. In the third test group, granulocyte drop was accompanied by a extremely large increase in the relative number of basophils. There is a significant drop in specific gravity of urine at the end of the research in the second and third experimental group. Proteinuria is a common finding to all experimental groups, while it was absent or only in traces in the control group. At the end of the experiment was determined to increase significantly the number of phosphate crystals in the experimental groups. The cylinders have appeared only in the urine in the third test group. The greatest number of changes in the urine is determined in the third experimental group.
Ardin, Maude. "Investigating cancer aetiology through the analysis of somatic mutation signatures." Thesis, Lyon, 2016. http://www.theses.fr/2016LYSE1236/document.
Full textCellular genomes accumulate alterations following exposures to exogenous factors, like environmental agents such as tobacco smoking or UV, or to endogenous mechanisms such as DNA replication errors. Analysing the causes and consequences of these changes allows a better understanding of the mechanisms underlying cancer development and progression. Next-generation sequencing (NGS) technologies provide the opportunity tostudy the nature of the resulting alterations on a genome-wide scale and started to reveal distinct mutational signatures specific to past carcinogenic exposures providing clues on cancer aetiology.The aim of my thesis was to develop user-friendly bioinformatic tools and methods for facilitating the analysis and interpretation of carcinogen-specific mutational signatures from NGS data. Applying these tools and methods to human tumours and experimental models of mutagenesis led to a better characterisation the mutational signature of aristolochic acid (AA), as well as other carcinogens of interest
Chan, Wan. "Development and application of liquid chromatography and electrospray-ionization mass spectrometry methods for herbal medicine analysis and for the studies of metabolism, DNA adducts and metabonomics of aristolochic acids." HKBU Institutional Repository, 2007. http://repository.hkbu.edu.hk/etd_ra/891.
Full textBooks on the topic "Aristolochia acids"
Gökmen, M. Refik, and Graham M. Lord. Aristolochic acid nephropathy caused by ingestion of herbal medicinal products. Edited by Adrian Covic. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0089.
Full textWeaver, Virginia M., Bernard G. Jaar, and Jeffrey J. Fadrowski. Kidney Disorders. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190662677.003.0031.
Full textRadović, Milan, and Adalbert Schiller. Balkan endemic nephropathy. Edited by Adrian Covic. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199592548.003.0090_update_001.
Full textBook chapters on the topic "Aristolochia acids"
Yan, Rong, Li Li, and Guan-Hua Du. "Aristolochic Acid." In Natural Small Molecule Drugs from Plants, 671–74. Singapore: Springer Singapore, 2018. http://dx.doi.org/10.1007/978-981-10-8022-7_108.
Full textSidorenko, Viktoriya S. "Biotransformation and Toxicities of Aristolochic Acids." In Advances in Experimental Medicine and Biology, 139–66. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-41283-8_9.
Full textVanherweghem, Jean-Louis, Frederic Debelle, Marie-Carmen Muniz-Martinez, and Joëlle Nortier. "Aristolochic acid nephropathy after Chinese herbal remedies." In Clinical Nephrotoxins, 579–86. Dordrecht: Springer Netherlands, 2003. http://dx.doi.org/10.1007/1-4020-2586-6_29.
Full textDebelle, Frédéric, Marie-Carmen Muniz-Martinez, Jean-Louis Vanherweghem, and Joëlle Nortier. "Herbal remedies containing aristolochic acid and mushroom nephrotoxicity." In Clinical Nephrotoxins, 757–69. Boston, MA: Springer US, 2008. http://dx.doi.org/10.1007/978-0-387-84843-3_33.
Full textJelaković, Bojan, Živka Dika, and Arthur P. Grollman. "Endemic (Balkan) Nephropathy: A Disease Caused by Aristolochic Acid." In Environmental and Food Safety and Security for South-East Europe and Ukraine, 219–27. Dordrecht: Springer Netherlands, 2012. http://dx.doi.org/10.1007/978-94-007-2953-7_20.
Full textChen, Chien-Ming, Yih-Huei Uen, Chen-Yi Kuo, Tzu-Chuan Huang, and Jen-Ai Lee. "Fluorimetric Determination of L-3-Hydroxybutyrate Concentrations in the Serum of Normal and Aristolochic Acid-Treated Mice." In Bio-Science and Bio-Technology, 63–68. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-642-10616-3_9.
Full textSchmeiser, H. H., J. Lyons, J. W. G. Janssen, C. R. Bartram, H. R. Scherf, W. Pfau, and M. Wiessler. "Aristolochic Acid I Induced Tumors in Wistar Rats Contain Activating Mutations in Codon 61 of the H-ras Protooncogene." In ras Oncogenes, 261–62. Boston, MA: Springer US, 1989. http://dx.doi.org/10.1007/978-1-4757-1235-3_33.
Full textLamari, Zohra, and Houria Negache. "Analysis of Aristolochia longa L. Medicinal Plant from Algeria." In Trace Elements and Their Effects on Human Health and Diseases. IntechOpen, 2021. http://dx.doi.org/10.5772/intechopen.95298.
Full textJordan, S. A., and S. Perwaiz. "Aristolochic Acids." In Encyclopedia of Toxicology, 298–301. Elsevier, 2014. http://dx.doi.org/10.1016/b978-0-12-386454-3.01164-7.
Full text"Aristolochic Acid Nephropathy." In Diagnostic Pathology: Kidney Diseases, 660–61. Elsevier, 2016. http://dx.doi.org/10.1016/b978-0-323-37707-2.50148-8.
Full textConference papers on the topic "Aristolochia acids"
Yu, Li-Rong, Zhiguang Li, Yuan Gao, and Tao Chen. "Abstract LB-438: Proteomic analysis of aristolochic acid-induced nephrotoxicity in rats." In Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-lb-438.
Full textEdwards, Karen L., Jia Yin Wang, Katherine Snappin, Zdenko Sonicki, Marcia Miletic-Medved, Arthur P. Grollman, and Bojan Jelakovic. "Abstract 1837: Exposure to Aristolochic Acid is associated with endemic (Balkan) nephropathy." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-1837.
Full textSidorenko, Viktoriya S., Kathleen G. Dickman, Thomas Rosenquist, Radha Bonala, Sivaprasad Attaluri, Irina Zaitseva, Charles Iden, Francis Johnson, and Arthur P. Grollman. "Abstract 5241: Using affinity probes to explore the nephrotoxicity of aristolochic acid." In Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-5241.
Full textAlkawari, Fatima, Wigdan Ali, Fatiha Benslimane, and Huseyin Yalcin. "Investigating the Cardiac effects of New Generation Anti-Diabetic Drug Empagliflozin using Zebrafish Embryo Model." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2020. http://dx.doi.org/10.29117/quarfe.2020.0211.
Full textGrollman, Arthur P. "Abstract PL02-02: Aristolochic acid-induced nephropathy and urothelial carcinoma: A preventable global disease." In Abstracts: Twelfth Annual AACR International Conference on Frontiers in Cancer Prevention Research; Oct 27-30, 2013; National Harbor, MD. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1940-6215.prev-13-pl02-02.
Full textLo, Fang Yin, Charles Valentine, Elizabeth Schmidt, Lindsey Williams, Arnoud Boot, Steve Rozen, and Jesse Salk. "Abstract 3147: Non-invasive detection of aristolochic acid exposure using ultra-sensitive duplex sequencing." In Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.am2020-3147.
Full textRosenquist, Thomas A., Penelope Strockbine, and Arthur P. Grollman. "Abstract 3253: Genetic loci that contribute to aristolochic acid nephropathy and associated upper urothelial cancer." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-3253.
Full textChen, Xiaoyi, Qinqin Chai, Xianghui Li, Jie Huang, and Wu Wang. "A Rapidly Method for the Discrimination of Aristolochic Acid and its Analogues Using SVM and PCA." In 2019 Chinese Control Conference (CCC). IEEE, 2019. http://dx.doi.org/10.23919/chicc.2019.8865305.
Full textCastells, Xavier, Sandra Karanovic, Magali Olivier, Maude Ardin, Florence Le Calvez-Kelm, Catherine Voegele, James McKay, et al. "Abstract 305: Ultra-low coverage exome sequencing of FFPE tumor specimens identifies exposure to carcinogenic aristolochic acid." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-305.
Full textMoussa, Heba Adel Mohamed Lotfy, Gawaher Saleh Abbas Mahgoub, Mashael Ali H. I. Al-Badr, and Huseyin Cagatay Yalcin. "Investigating the Cardiac Effects of Sildenafil loaded Nanoparticles on Heart Failure using the Zebrafish Embryo Model." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2020. http://dx.doi.org/10.29117/quarfe.2020.0217.
Full text